The short answer is yes—Maine’s Death with Dignity law remains legal after the 2026 amendments, and the recent changes actually broaden the circumstances under which a terminally ill resident may request physician‑prescribed lethal medication. The 2026 statute, codified at Me. Rev. Stat. tit. 17, § 2501‑c, preserved the core safeguards while adding a streamlined assessment process and expanding eligibility to patients with advanced neurodegenerative diseases who meet the prognostic standards.
Legal Background
Maine enacted the Death with Dignity Act in 2019, becoming the fifth New England state to permit medically assisted death for competent adults with a prognosis of six months or less to live. The original law required two physicians’ confirmation, a 15‑day waiting period, and a mandatory mental‑health evaluation if depression was suspected. Since its enactment, over 1,200 prescriptions have been issued, according to the Maine Department of Health and Human Services.
2026 Legislative Changes
In 2026 the legislature passed Bill 742, which amended the act in three key ways:
- Eligibility expansion – patients diagnosed with amyotrophic lateral sclerosis, advanced multiple sclerosis, and certain forms of Huntington’s disease may now qualify if their life expectancy meets the six‑month threshold.
- Assessment streamlining – the waiting period was reduced from 15 days to 7 days, and a single consulting physician may now substitute for the second confirming doctor when the patient resides in a medically underserved area.
- Enhanced oversight – a new “Death with Dignity Review Board” must receive a de‑identified quarterly report to ensure compliance and monitor adverse outcomes.
These amendments were passed with a bipartisan 92‑30 vote and signed into law on July 1, 2026.
Current Eligibility Criteria
- Age 18 or older and a resident of Maine.
- Competent to make medical decisions, confirmed by a licensed physician.
- Diagnosis of a terminal illness with a prognosis of six months or less, including the newly added neurodegenerative conditions.
- Voluntary written request, witnessed by two non‑family adults.
- Completion of the 7‑day waiting period, unless a waiver is granted for remote‑area patients.
Process for Patients
- Initial Consultation – the patient meets with a primary physician who discusses prognosis and alternatives.
- Second Confirmation – a consulting physician reviews the case; telemedicine is permissible when travel is impractical.
- Written Request – the patient signs the statutory form, which is filed with the state health department.
- Prescription Issuance – after the waiting period, the prescribing physician provides the medication, accompanied by counseling on administration and possible side effects.
Potential Legal Challenges
Opponents have filed an injunction arguing that the 2026 expansion violates the Maine Constitution’s protection of life. The case, Maine Right to Life v. State, is pending before the Supreme Judicial Court, but earlier rulings in Doe v. Maine (2022) upheld the original act’s constitutionality, suggesting the court may maintain the law’s validity.
FAQ 1: Does the 2026 law allow a patient to waive the waiting period?
No. The waiting period can only be shortened to seven days; a full waiver is not permitted under current statutes.
FAQ 2: Can a minor request physician‑assisted death in Maine?
No. The law expressly limits eligibility to adults 18 years of age or older.
FAQ 3: What documentation is required for a patient with ALS?
The patient must provide a recent neurological assessment, a life‑expectancy estimate from a specialist, and the standard two‑witness written request.
FAQ 4: Are hospice providers involved in the process?
Hospice staff may act as witnesses, but they are not required to participate in the medical assessment or prescription.
FAQ 5: How does the Review Board enforce compliance?
The board audits all completed requests, reviews adverse‑event reports, and may issue corrective actions or refer violations to the Attorney General’s office for prosecution.